Objective: We have previously shown that microfractured ovine defects are repaired with more hyaline cartilage when the defect is treated with in situ-solidified implants of chitosaneglycerol phosphate (chitosaneGP) mixed with autologous whole blood. The objectives of this study were (1) to characterize chitosaneGP/blood clots in vitro, and (2) to develop a rabbit marrow stimulation model in order to determine the effects of the chitosaneGP/blood implant and of debridement on the formation of incipient cartilage repair tissue.
Introduction
Partial thickness cartilage lesions fail to heal and often lead to further degeneration and joint disease 1 . Focal cartilage lesions can be resurfaced in human patients 2e4 and in experimental defects in animals 5e10 when residual cartilage is removed, and access to the vascularized bone marrow provided through abrasion arthroplasty, or debridement and microfracture or drilling 2e4 . However, in both patients 11 and animal models 5e10 , the resulting repair tissue is typically fibrocartilaginous or fibrous, tissue types known to have weak biomechanical properties and reduced wear capacity compared to hyaline cartilage, which contains high levels of collagen type II and glycosaminoglycans (GAG) 5, 12 . Bone marrow-derived repair cells can give rise to a degree of cartilaginous repair tissue in young rabbits 7, 12, 13 , however, this repair occurs only sporadically in adult rabbits 5e7 . Repair processes, which reliably lead to hyaline cartilage regeneration and integration in skeletally mature defects have yet to be elucidated.
Since bleeding has been identified as an initiating event in post-surgical repair 2e4 , we hypothesized that microfracturebased repair could be improved by stabilizing the clot formed in the lesion with a polymer that is thrombogenic and actively stimulates the wound repair process. Chitosan is a positively charged polymer composed of (1 / 4)-b-linked glucosamine and acetyl-glucosamine residues. Previous studies have shown that chitosan is hemostatic 14e17 , and when left in the wound site, stimulates revascularization of the wound 14 and connective tissue repair 14,18e20 . Chitosan is also biodegradable 17, 21, 22 , non-immunogenic 23, 24 , and adheres to connective tissues including cornea, bone, and cartilage 25, 26 . We discovered a means of solubilizing chitosan under physiological conditions by combining it with glycerol phosphate to form chitosaneglycerol phosphate (chitosaneGP) solutions 27e29 . And in a recent study we showed that mixtures of whole blood with chitosaneGP could form solid implants above microfractured cartilage defects 26 . These implants adhered more to the defect than normal clots, and elicited significantly more hyaline repair compared to microfracture alone in an ovine model at 6 months 26 . In the study presented here, we describe the development of a bilateral rabbit cartilage repair model to efficiently screen implants for their ability to improve repair of marrowstimulated defects as well as to elucidate mechanisms of action. This model was used to test the hypothesis that hyaline cartilage repair after marrow stimulation depends upon the surgical approach and the use of chitosaneGP/ blood implants. ChitosaneGP stabilized blood clots were made by combining chitosaneGP solutions with peripheral whole blood from human volunteers, or with blood from two distinct animal species used in cartilage repair studies, rabbit and sheep. Our surgical model was based on a rabbit model previously published by Mitchell and Shepard 6 , representing a scaled-down version of human lesions that are treated by microfracture or drilling. This is in contrast to other rabbit models where repair was observed over single, large osteochondral drill holes 13, 30, 31 which do not mimic human lesions. The generation of rectangular trochlear defects with precisely placed drill holes also permitted us to analyze the effect of treatment on repair tissue formed directly over the drill holes, compared to repair tissue formed over the defect surface between the drill holes.
Methods

MATERIALS
Ultrapure chitosan was obtained from BioSyntech (77.1% degree of deacetylation (DDA), <375 endotoxin units (EU)/ g; 79% DDA, <3000 EU/g; 83.4% DDA, <500 EU/g free base from Laval, QC, Canada) or Pronova (84.5% DDA, 130 EU/g, HCl salt from Oslo, Norway). BioSyntech chitosan was dissolved at 1.66% w/v or at 1.89% w/v (taking into account loss on drying) in 60 mM to 83 mM HCl and autoclave-sterilized. Pronova chitosan was lyophilized, weighed, sterilized by exposing the powder to UV light for 90 min, and then dissolved in sterile MilliQ-filtered water at 1.66% w/v, taking into account HCl salt content. Sterile chitosan solutions were combined with filter-sterilized disodium beta-glycerol phosphate (Tissue Culture grade, Sigma, St. Louis, MO) to yield transparent solutions with 1.5% w/v or 1.7% w/v chitosan with 135 mM glycerol phosphate (also called BST-CarGel Ò ), pH 6.8, osmolality of 470 mOsm, and viscosity of 250e1100 mPa s at 25 C, that were stored at À80 C.
BLOOD COLLECTION AND CHITOSANeGP/BLOOD MIXTURES All protocols involving animals were approved by institutional animal care committees and all protocols involving human subjects were approved by an Internal Review Board Ethical Committee. Peripheral whole blood was collected aseptically from the central ear artery from 15 New Zealand White rabbits with atravet or ketamine/xylazine/buprenorphine and isoflurane gas anesthesia and the jugular vein of 10 sheep with or without ketamine/diazepam and halothane gas anesthesia. Anesthetics can affect platelet function 32 , however, whole blood clotting times from anesthetized animals and unanesthetized humans were similar to published values 33 . Venous blood was collected aseptically from non-fasting healthy volunteers (n ¼ 7, 23e43 years old). Non-activated whole blood was drawn into plastic syringes after a 2 mL first discard, with a 21-gauge 3/4 inch butterfly needle with female luer and outlet needle. Homogeneous aseptic mixtures were obtained by filling 4.0 mL Wheaton glass vials with plastic screwcaps to capacity with 1.1 mL chitosaneGP solution, 3.3 mL fresh blood, and six surgical 316 stainless steel mixing beads (4.5 mm diameter, Salem Specialty, Canton, CT), closing the vials, and shaking vigorously for 10 s.
BLOOD SMEARS, CLOTTING TIME, CLOT RETRACTION, AND HEMOLYSIS MEASUREMENTS Blood smears were generated with blood or chitosaneGP/ blood mixtures within 3 min after mixing and stained with May Grunwald Geimsa (Sigma, St. Louis, MO). Clotting time was measured using the LeeeWhite clotting test in dry, sterile, non-siliconized glass tubes with vented steel caps and 0.5 mL sample volumes 34 . Tubes containing 0.5 mL solid clot samples were transferred to a humidified 37 C incubator for 4 h to determine percent retraction by weighing separately the excluded serum and mass of the solid clot. Hemolysis was determined by serum hemoglobin absorbance at OD 530 using an enzyme-linked immunosorbent assay (ELISA) plate reader, modified from a previous method 35 . FEASIBILITY 
STUDIES
To test the effect of removal of the calcified cartilage layer on repair with or without implant, bilateral defects were created identically in each trochlear groove in the knees of skeletally mature rabbits. In three rabbits, defects were debrided into, but not beyond, the calcified cartilage while in another three rabbits, bilateral defects were completely debrided of the calcified layer to bleeding cancellous bone. All defects were then pierced with four or five, 0.9 mm diameter 3 mm deep holes with either a drill bit or a custom-made pick and hammer. ChitosaneGP/blood implant was solidified in one defect while the contralateral defect was allowed to bleed as a surgical control. Defects were allowed to repair for 7e11 weeks then fixed, decalcified, processed in LR White plastic resin, stained with Toluidine Blue and analyzed histologically.
RABBIT CARTILAGE REPAIR MODEL Thirty-eight bilateral defects were created in the knees of 19 skeletally mature New Zealand White rabbits (9e15 month old females, 4.6 AE 0.8 kg, Table I ). Three of these rabbits were used to evaluate the initially debrided defects at 1 day post-op while defects in the remaining 16 rabbits were evaluated at 8 weeks post-op. Rabbits were anesthetized by an intramuscular injection of ketamine/xylazine/ buprenorphine, and maintained on 3% isoflurane/oxygen. The ears (phlebotomy site) and legs were shaved and disinfected with Baxedin, poviodine, and 70% ethanol. Cartilage defects were created in each trochlear groove using sequential bilateral arthrotomies with a medial parapatellar incision followed by patellar luxation. Joint surfaces were kept moist with sterile phosphate buffered saline (PBS) irrigation every 30e60 s to maintain viability of cells in the exposed articular and calcified cartilages. Chondral defects (3.5 Â 4 mm) were made in the center of the trochlear groove to a depth of around 200 mm, 3e5 mm above the lateral collateral ligament insertion, by scraping with 1.5e2.75 mm flat surgical blades (Fine Science Tools, North Vancouver, B.C., Canada) into the calcified cartilage. Four, 3e4 mm deep microdrill holes were then generated in each of the corners of the defect using a high-speed, handheld microdrill and 0.9 mm diameter drill bit (Fine Science Tools, North Vancouver, B.C., Canada) with constant 4 C PBS irrigation to avoid thermal necrosis and to wash away bone debris. Bleeding from subchondral holes, which was minimal in >10 month old rabbits, was additionally promoted by inserting a 26-gauge 1/2 inch needle into each hole. Once the defects were hemostatic, freshly drawn whole blood was mixed with chitosaneGP (79% DDA chitosan), drawn into a 1 cc syringe with a 20-gauge needle, and one drop (w25 mL) deposited directly onto the horizontally held defect within 2 min of mixing where the implant solidified within 7e9 min. These w25 mL implants were larger than the 3.5 Â 4 Â 0.2 mm chondral defect volume (w2.8 mL), and completely covered the defect. Defects were treated with chitosaneGP/blood in alternating right and left knees (Table I) . Contralateral defects were allowed to fill with bone-derived blood without further intervention, as in standard drilling procedures 2 and served as controls. The patella was repositioned and the knee closed in sutured layers. Animals were allowed immediate unrestrained activity in cages after recovery from anesthesia, and received buprenorphine anti-pain medication twice daily for 3 days following arthrotomy. No antibiotics were given. All joints at sacrifice were free from infection, and at necropsy rabbits had neither effusions nor weight loss. Eight out of the 16 rabbits were housed in free-range enclosures (2.6 Â 2.7 m) prior to surgery and for the final 4e6 weeks of the 8 week repair period while all other rabbits were housed in cages (0.6 Â 0.6 Â 0.4 m, lengthewidtheheight) for the entire repair period.
HISTOPROCESSING AND IMMUNOHISTOCHEMISTRY
All clot samples were fixed after 1e4 h post-solidification in 4% glutaraldehyde/PBS or 10% buffered formalin and then either processed in LR White plastic resin and stained with Toluidine Blue, or processed in paraffin and stained with Safranin O/Fast Green/Iron Hematoxylin to identify chitosan by specific Fast Green-specific staining characteristics 36 . Immediately after sacrifice, distal femora were recovered, dissected of all soft tissues and fixed for 3 days in 4% paraformaldehyde/1% glutaraldehyde/100 mM sodium cacodylate, pH 7.2. Defects from 1 day post-op were decalcified in ethylenediaminetetraacetic acid (EDTA), and cryosections generated from the middle of each defect and stained with Safranin O/Fast Green. Defects after 8 weeks of repair were decalcified in 0.5 M HCl/0.1% glutaraldehyde for 7e10 days then trimmed and bisected transversely with a razor between the drill holes. The proximal defect half was embedded in LR White plastic resin, while the distal half was embedded in paraffin. Five to 20, 1 mm-thick plastic sections were generated in the proximal half of the repaired defects, including between the drill holes, within the drill holes, and proximal to the drill holes and stained with Toluidine Blue. Paraffin sections 6 mm thick were generated from the distal half within the drill holes, then dewaxed, digested with 2.5% w/v hyaluronidase and processed by immunohistochemistry as previously described 37 for collagen type II using monoclonal II-II6B3 (DSHB, Iowa, USA) at 1:10 dilution, biotinylated goat antimouse diluted to 22 mg/mL, and avidin-Alkaline Phosphatase-red substrate detection (Vector Laboratories Inc., Burlington, Ontario, Canada), followed by light Iron Hematoxylin counterstain. Control isotype antibody or omission of primary antibody showed no staining.
QUALITATIVE HISTOLOGICAL SCORING AND QUANTITATIVE HISTOMORPHOMETRY
Four to 12 sections from distinct areas within the proximal half of each defect were graded by a blinded observer using the O'Driscoll score 31 , with the exception that staining intensity was determined with Toluidine Blue instead of Alcian Blue. The score for normal cartilage is 24 31 . This evaluation revealed that the edge of the ''tufts'' of repair tissue covering the drill holes contained less differentiated cells than the center of the tufts, as previously reported by Mitchell and Shepard 6 . Therefore, one section in the middle of the holes and one section between the holes were selected from each defect to compare O'Driscoll scores. All histomorphometric and stereologic analyses were performed on these same two plastic-embedded sections by a blinded observer, using a Zeiss Axiovert microscope, digital camera, and histomorphometric software (Northern Eclipse, Empix Imaging, Mississauga, ON) to measure the width of the cross-section of each defect, the percent of different tissues covering the defect (repair tissue, bone or calcified cartilage), and the percent of repair tissue clearly detached from the base of the defect. The same histomorphometric analysis for percent of different tissues covering the initial defects was performed on one section from the middle of each defect after 1 day of repair (n ¼ 3 sections per condition). In sections from defects repaired for 8 weeks, percent of integrated repair tissue was determined as the total length of the repair tissue attached to the defect base divided by the defect width. Repair tissue area was determined as the cross-sectional area of tissues above subchondral bone, excluding bone, and excluding soft tissues occasionally present in the drill holes. Collagen type II staining in repair tissue above the subchondral bone was quantified by threshold analysis as the percent of total repair tissue area that stained pink and light red, vs a dark red hue that matched the staining intensity of normal cartilage 37 . For stereology measurements, digital print-outs were generated of a segment of subchondral bone directly beneath the repair tissue (250 mm deep, the entire width of the defect) to measure bone porosity. Histologically identified pores were traced with a line tool to render them more visible. A grid with 19.75 mm Â 19.75 mm squares was randomly positioned over the sample image and the number of intersections (I ) of grid lines with the surfaces 
Chitosan blood clots elicit hyaline repair of all pores was manually counted. In addition, we counted the number of points (grid intersections) that fell within all bone pores (P) and within the entire bone sample (B), the latter serving as a reference volume 38 . Pore surface area per reference volume (Sv in mm 2 /mm 3 ) was calculated according to the equation Sv ¼ I/(B Â 0.01975 mm) 38 . Pore volume per reference volume (Vv, in percent m 3 /m 3 ) was obtained according to the equation Vv ¼ P/B 38 . Some degree of sampling bias was present in these measurements, due to the unavoidable anisotropy and non-random orientation of the osteochondral sections.
STATISTICAL ANALYSIS
To test the hypothesis that treatment affected repair, differences in O'Driscoll histological scores were analyzed by the ManneWhitney U test for one section per defect over the holes (n ¼ 16) and one section per defect between the 
holes (n ¼ 16) (Statistica version 6.1, Tulsa, OK). Differences were considered significant for P exact values, P < 0.05. The Student's t test was used to determine whether clot retraction was significantly different between chitosaneGP and normal blood clots 4 h post-solidification, and whether chitosaneGP/blood implants significantly improved histomorphometric and stereological variables compared to blood clots alone. Correlation coefficients were obtained by multivariate analysis of covariate scatterplots (Statistica version 6.1, Tulsa, OK) with significance determined when P < 0.05.
Results
CHITOSANeGP SOLUTIONS STABILIZE BLOOD CLOTS
Mixing experiments were performed in order to create hybrid chitosan blood clots that solidified within 10 min. Trials with different ratios of blood and chitosaneGP solutions revealed that homogeneous chitosaneGP/blood clots formed most rapidly using a ratio of 1 volume chitosaneGP to 3 volumes whole blood from rabbit, sheep, or human. After 1 h at 37 C, whole blood clots retracted up to 40% of their original mass, were stiff and non-elastic [ Fig. 1(A,B) ]. In contrast, hybrid chitosaneGP/blood clots containing final concentrations of 0.4% w/v chitosan and 34 mM glycerol phosphate were firm and elastic [ Fig. 1(C,D) ]. Mixture of chitosan without glycerol phosphate (pH 4.7) into whole blood resulted in unstable and brittle clots with substantial hemolysis that was not seen in normal clots or in chitosaneGP/blood clots (data not shown). Compared to normal clots [ Fig. 1(E,G) ], chitosaneGP/blood clots were comprised of a chitosan scaffold homogeneously dispersed among clumps of red blood cells (RBCs) with histologically visible fibrin-like fibers [ Fig. 1(F,H) ]. In blood smears generated from fresh chitosaneGP/blood mixtures, chitosan specifically mediated adhesion between RBCs (Fig. 1 , compare panels I and J). ChitosaneGP/blood clots retracted significantly less than the normal clots [ Fig. 1(AeD) ] in three different species (P < 0.0001, Fig. 2 ).
EFFECT OF SURGICAL DEBRIDEMENT ON CARTILAGE REPAIR
In skeletally mature rabbits, the trochlear calcified cartilage layer had an average thickness of 77 AE 20 mm, sometimes attaining half the thickness of the non-mineralized articular cartilage, which in the area of the defects had an average thickness of 160 mm AE 41 mm (n ¼ 6). A preliminary study was performed to examine the effect of debridement of the calcified layer on cartilage repair. Complete debridement of the calcified layer to the bleeding cancellous bone followed by marrow stimulation led to severe subchondral bone resorption and fibrous repair [ Fig. 3(A,C,E) ]. By comparison, defects that were debrided into the calcified layer, drilled, and treated with chitosaneGP/blood implant developed variable amounts of hyaline repair tissue [ Fig. 3(B,D,F) ]. Based on these results, our study was conducted using drilled defects that had been debrided into, but not beyond, the calcified layer [ Fig. 4(A) ]. Control defects were allowed to fill with bone-derived blood [ Fig. 4(A) , inset], while treated defects were filled with chitosaneGP/ blood which formed a solid implant after 7e10 min [ Fig. 4(B) , Table I ]. Histomorphometry of initial defects showed that an average 40% of the cross-section of the defect between the drill holes was covered by residual calcified cartilage, the remainder of the defect consisting of exposed subchondral bone [n ¼ 3, Fig. 5(A) ].
EFFECT OF THE CALCIFIED LAYER AND CHITOSANeGP/ BLOOD IMPLANTS ON BONE REPAIR, AND THE INTEGRATION AND QUALITY OF CARTILAGE REPAIR
After 8 weeks of repair, an animal-specific, bilaterally consistent macroscopic filling was seen in the trochlear defects. In 11 rabbits, bilateral defects were covered with tufts of repair tissue over the drill holes [ Fig. 4(C,D) ], while in five rabbits, both defects were completely resurfaced [ Fig. 4(E,F) ]. Control repair tissue was typically white and streaky while treated repair tissue was white and glassy. Histological sections taken between the drill holes showed that defects with tufts of repair tissue had persistent calcified cartilage [ Fig. 6(AeD) ]. In some rabbits, the control defect between the drill holes was completely devoid of repair tissue [ Fig. 6(A,C) ], while the contralateral treated defect contained tufts of hyaline repair tissue growing above porous bone and breaching the calcified layer [ Fig. 6(B,D) ].
Histomorphometry of the tissues covering the defects after 8 weeks of repair revealed that less average calcified cartilage was present compared to the initial defects, with correspondingly less calcified cartilage remaining in treated defects both between and through the drill holes [ Fig. 5(A)] . A similar average volume of repair tissue covered the control and treated defects [ Fig. 5(B) ]. However, in many control defects, the repair tissue was growing from the drill holes and over, but not integrating with, the defect base [ Figs. 6(E,G), 7(A,B) ]. An average 12% of repair tissue covering the control defects between the drill holes was detached from the base of the defect, while only 1% of repair tissue covering treated defects was detached [P < 0.05, Fig. 5(C) ]. Treated defects were resurfaced with more integrated repair tissue between the drill holes [76% treated vs 39% control, P < 0.005, Fig. 5(C) ]. After 8 weeks of repair, repair tissues in many defects had not yet reached the edges of the defect, giving a median score of 0 for bonding with the adjacent cartilage total O'Driscoll scores (P values: P < 0.05 to P < 0.0005, Table II ). More remarkable histological differences between treated and control repair tissues were observed between the drill holes and these differences are summarized in Table II . Fig. 3 . Development of fibrous or hyaline repair following marrow stimulation depends on the extent of debridement. Bilateral trochlear defects were generated in the knees of skeletally mature rabbits by debriding the calcified cartilage layer completely and administering five microfracture holes (A) or by debriding into the calcified cartilage layer and piercing four microdrill holes (B). In each rabbit, one defect was allowed to fill with bone marrow-derived blood (for example, A, inset), while the contralateral defect was filled with chitosaneGP/blood which was allowed to clot in situ (for example, B, inset). Repair at 7e11 weeks showed that defects debrided of the calcified layer had extensive subchondral bone resorption and fibrous tissue repair (C and E), while more hyaline repair was seen in defects debrided slightly into the mineralized zone with no visible punctuate bleeding that were then drilled, and treated with chitosaneGP/blood implant (D and F). Arrows: resorbed bone. AC: articular cartilage layer.
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Hyaline repair was frequently associated with porous, vascularized subchondral bone [ Fig. 6(D,H) , open arrows; Fig. 7 (E), dotted black circles]. In the superficial 250 mm of the repaired subchondral bone plate, treatment was found to increase the pore surface area (Sv) and pore volume (Vv) over the holes [P < 0.005, Fig. 5(E,F) ]. This effect was partly due to the fact that in many controls, the microdrill holes had repaired with fibrous tissue instead of bone [ Fig. 7(B) ]. A lack of bone repair at 8 weeks in the microdrill holes was associated with fibrous or fibrocartilage repair [ Fig. 7(C) ]. Treatment also increased Sv and Vv between the holes (P < 0.005), consistent with the observation that treatment elicited remodeling of the subchondral bone plate between the drill holes at earlier time points, between 2 and 5 weeks post-surgery 39 . Sv correlated positively with Vv for all 32 defects (P < 0.0001), approximately doubling in Fig. 4 . Appearance of defects and implant at surgery, and bilateral repair at 8 weeks post-surgery. All defects were debrided into the calcified layer with four drill holes (A) and allowed to bleed as a control (inset of A, C, and E) or treated with chitosaneGP/blood implant (B, D, and F). Two patterns of repair were observed where bilateral defects either had tufts of tissue growing from the drill holes in 11 out of 16 rabbits (C and D) or were completely resurfaced in five out of 16 rabbits (E and F). Treated defects had a distinct macroscopic appearance compared to surgery-only controls. The single and double arrows indicate the areas used to generate plastic Toluidine Blue-stained sections through and between the drill holes for histomorphometric, histological, and stereological analyses. The triple arrow indicates the region where paraffin sections were generated for collagen type II immunostaining over the distal holes. 84 C. D. Hoemann et al.: Chitosan blood clots elicit hyaline repair both cases, thereby maintaining a similar pore volume to surface area ratio. These data suggest that gross pore morphology was not altered by treatment, but rather that the pore number was increased by treatment throughout the bone immediately below the defect. The average Sv of the subchondral bone plate below control vs treated defects . Symbols: x ¼ samples from day 1 postoperative; *P < 0.05, **P < 0.005, and ***P < 0.0005, compared to control; #P < 0.05 for detached repair tissue compared to treated, and ##P < 0.005 for integrated repair tissue compared to control. 
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Osteoarthritis and Cartilage Vol. 15, No. 1 subchondral bone both over (P < 0.005) and between microdrill holes (P < 0.01). Other predictive relationships between variables were only observed between the drill holes and not over the drill holes. Between drill holes, the absence of calcified cartilage predicted a higher total O'Driscoll score (P < 0.005), while a higher bone pore surface area (Sv) in the subchondral plate was a predictor of better repair tissue integration (P < 0.005), and a higher total O'Driscoll score (P < 0.01).
Discussion
CLOT STABILIZATION BY CYTOCOMPATIBLE CHITOSAN SOLUTIONS
ChitosaneGP/blood clots are novel implants with wound-healing properties originating both from whole blood components, and the chitosan itself. Acidic chitosan solutions and solid chitosan substrates have been previously shown to be pro-coagulatory 14 , by generating a RBC thrombus 16 , and by promoting platelet aggregation and degranulation 15e17,41e43 . Our data now extend these observations to show that liquid mixtures of whole blood and chitosaneGP can generate solid, homogeneous polymer-reinforced hybrid clots. ChitosaneGP solutions mediated erythrocyteeerythrocyte adhesion, suggesting that the surgically implanted chitosaneGP/blood clot implants had greater bonding between RBCs than normal clots. The available data 41, 44 suggest that platelets are activated in the hybrid chitosaneGP/blood clots, but are somehow inhibited from fully retracting the fibrin network. Clot retraction can be inhibited by interruption of the fibrine platelet integrin receptor complex 45 via blocking antibodies 46 or genetic defects in the platelet integrin receptor Fig. 7 . ChitosaneGP/blood implants create a repair tissue at 8 weeks that is more integrated, with more intense collagen type II expression over porous bone. Immunohistochemistry for collagen type II is shown for repaired bilateral defects from a rabbit where the defect was completely resurfaced. Repair over former drill hole is indicated for respective defects (black arrows, upper panels), and the region under the arrow shown at successively higher magnifications directly below. In this representative control defect (A, B, and C), the drill holes had incomplete bone repair, with a fibrocartilage tissue growing over the defect which failed to attach to the bone, with somewhat lighter superficial collagen type II stain and a non-porous subchondral bone plate (A, C, and E). The contralateral chitosaneGP/blood treated defect had a homogeneous complete repair of the drill holes with porous bone (dotted black circles, E), complete tissue integration (A and E), and a more hyaline appearance with columnar cell organization and higher cell density (F). 86 C. D. Hoemann et al.: Chitosan blood clots elicit hyaline repair (GPIIb, GPIIIa) 45, 47 , suggesting that chitosan may interfere with fibrineplatelet interactions. Given that chitosaneGP/ blood clots solidified after a 5e10 min delay, retracted slightly, and contained thin fibrin-like fibers, it nonetheless appears that the clotting cascade and generation of a fibrin network are part of the structural stabilization of the hybrid chitosaneGP/blood clot.
CHITOSANeGP/BLOOD CLOTS STIMULATE CHANGES IN THE SUBCHONDRAL BONE PLATE THAT LEAD TO HYALINE CARTILAGE REPAIR
A bilateral rabbit cartilage repair model was developed to study the effect of chitosaneGP/blood implants on cartilage repair following marrow stimulation. After 8 weeks of repair, a similar average amount of repair tissue was formed in control and treated defects although the repair tissue integration and quality were significantly improved by treatment. In this rabbit study, as well as in our previous ovine cartilage repair study 26 , chitosaneGP/blood implants elicited a more hyaline and cellular repair cartilage in marrow-stimulated defects compared to marrow stimulation alone. The repair tissue in treated rabbit defects was still somewhat heterogeneous and was not entirely composed of hyaline cartilage, which could be partly related to the early time point studied, and also to the use of trochlear defects which developed significantly less hyaline cartilage repair than condylar defects in sheep 26 . We have found that an 8-week repair period in this particular rabbit model was a minimal yet sufficient time period needed to measure a significant improvement in repair over controls. Longer repair periods in this rabbit model will allow us to characterize repair tissue durability.
The aim of marrow stimulation is to generate access channels for repair cells, including pluripotent bone marrow stromal cells, to migrate into the chondral defect and possibly give rise to chondrocytes and hyaline cartilage matrix. In all drilled defects, hyaline cartilage repair was frequently detected in areas where bone repair or remodeling gave rise to a porous bone plate Table II , between holes]. Taken together, these observations are consistent with the notion that chondral precursors can gain access to the defect by regenerating or remodeling bone. The failure of integrated repair tissue to form over large areas of calcified cartilage in this study [ Fig. 6(A) ], and in other studies 8e10,48,49 could be partly explained by the inability of marrow-derived repair cells to adhere to, and migrate over, large areas of mineralized tissue containing negatively charged GAG. Repair tissue was able to form over debrided bone in controls [ Fig. 5(B) , 6(G), 7(B)], however, the tissue frequently failed to adhere [ Fig. 5(C) ], as previously observed after resurfacing procedures in rabbit 6 and human patients 2 . The formation of more integrated and hyaline tissue by chitosan clot implants could be related to several mechanisms. Residual chitosan clot implant adhering to trochlear calcified cartilage and bone 26 could potentially provide an adhesive surface onto which repair tissues growing from the marrow holes could attach. Stimulation by chitosan clots of bone remodeling between the drill holes 39 , and remodeling and resorption of the calcified cartilage layer [Figs. 5(A), 6(B)] could give direct access to the defect by marrow cells in the bone plate, including blood microvessel pericyte chondral progenitors 50 . Finally, chitosan clots stimulated cell recruitment and transient subchondral angiogenesis during acute repair 39 , which in this study, and also in our ovine model 26 , led to the generation of a porous, revascularized subchondral bone plate [Figs. 5(E,F), 6(D,H), 7(E)]. Cartilage repair tissue integrated with a local vascular supply protected by bone could serve to provide progenitors, oxygen and nutrients, or other marrow-derived factors that stimulate chondrogenic proliferation, differentiation, and hyaline matrix production. 
